Medscape

First-in-Human Trial Supports Safety, Feasibility of Stem Cell Therapy in Prenatal Spina Bifida Repair

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
Medscape

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.
The American Journal of Managed Care

If a BTK Inhibitor Comes First in MCL, What Comes Next?

Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, as well as the emerging role of immunotherapy, according to a new review ...
ascopubs.org

Eftilagimod Alpha Plus Pembrolizumab in First-Line Metastatic Non–Small Cell Lung Cancer: Results From a PD-L1–Unselected Population in the TACTI-002 Study

Low-Dose Total Skin Electron Beam Radiotherapy in Stage IB-IIB Mycosis Fungoides: Results From the Prospective S-MISR Study Eftilagimod alpha (efti), an antigen-presenting cell (APC) activator, may ...
Targeted Oncology

Exploring TIL Sequencing in Melanoma Based on European Experience

During a live event, Daniel Olson, MD, discussed data and experience using tumor-infiltrating lymphocytes in melanoma.